Esperion Therapeutics Market Cap

Esperion Therapeutics has a market cap or net worth of 351.96 million as of January 23, 2025. Its market cap has increased by 70.50% in one year.

Market Cap

351.96M

Enterprise Value

452.84M

Revenue

220.44M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.15

Market Cap Chart

Since June 26, 2013, Esperion Therapeutics's market cap has increased from 137.93M to 351.96M, an increase of 155.18%. That is a compound annual growth rate of 8.43%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2025	343.85M	-0.69%
Dec 31, 2024	346.25M	29.71%
Dec 29, 2023	266.94M	-29.93%
Dec 30, 2022	380.99M	68.53%
Dec 31, 2021	226.06M	-57.42%
Dec 31, 2020	530.87M	-56.85%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	167.37B
GSK plc	55.25B
Haleon	33.81B
Smith & Nephew	8.96B
ConvaTec Group	4.94B
Hikma Pharmaceuticals	4.62B
HUTCHMED (China)	1.99B
Oxford Nanopore Technologies	1.42B

Market Cap Rankings